SSIs offer risks, not benefits during pregnancy, study says

11/2/2012 | Medscape (free registration)

Taking selective serotonin reuptake inhibitors while pregnant raises a woman's risk of miscarriage, preterm birth and neonatal complications, researchers from Beth Israel Deaconess Medical Center reported. They said there isn't strong data showing benefits, either for mothers or infants, and advised women to discuss use of the medications with their health care practitioner.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA